Growth of H5N1 Influenza A Viruses in the Upper Respiratory Tracts of Mice

Highly pathogenic avian H5N1 influenza A viruses have spread throughout Asia, Europe, and Africa, raising serious worldwide concern about their pandemic potential. Although more than 250 people have been infected with these viruses, with a consequent high rate of mortality, the molecular mechanisms responsible for the efficient transmission of H5N1 viruses among humans remain elusive. We used a mouse model to examine the role of the amino acid at position 627 of the PB2 viral protein in efficient replication of H5N1 viruses in the mammalian respiratory tract. Viruses possessing Lys at position 627 of PB2 replicated efficiently in lungs and nasal turbinates, as well as in cells, even at the lower temperature of 33 °C. Those viruses possessing Glu at this position replicated less well in nasal turbinates than in lungs, and less well in cells at the lower temperature. These results suggest that Lys at PB2–627 confers to avian H5N1 viruses the advantage of efficient growth in the upper and lower respiratory tracts of mammals. Therefore, efficient viral growth in the upper respiratory tract may provide a platform for the adaptation of avian H5N1 influenza viruses to humans and for efficient person-to-person virus transmission, in the context of changes in other viral properties including specificity for human (sialic acid α-2,6-galactose containing) receptors.

[1]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[2]  Yoshihiro Kawaoka,et al.  Early Alterations of the Receptor-Binding Properties of H1, H2, and H3 Avian Influenza Virus Hemagglutinins after Their Introduction into Mammals , 2000, Journal of Virology.

[3]  P. Massin,et al.  Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. , 2000, The Journal of general virology.

[4]  K. Omoe,et al.  Evolutionary characterization of the six internal genes of H5N1 human influenza A virus. , 2000, The Journal of general virology.

[5]  J. Paulson,et al.  Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. , 1983, Virology.

[6]  Y. Guan,et al.  Avian flu: H5N1 virus outbreak in migratory waterfowl , 2005, Nature.

[7]  H. Goto,et al.  Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong , 1999, Journal of Virology.

[8]  P. Massin,et al.  Residue 627 of PB2 Is a Determinant of Cold Sensitivity in RNA Replication of Avian Influenza Viruses , 2001, Journal of Virology.

[9]  J. Paulson,et al.  Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. , 1983, Virology.

[10]  Marion Koopmans,et al.  Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Murphy,et al.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range , 1993, Journal of virology.

[12]  Prasert Auewarakul,et al.  Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. , 2005, The Journal of general virology.

[13]  Y. Guan,et al.  Characterization of a Human H5N1 Influenza A Virus Isolated in 2003 , 2005, Journal of Virology.

[14]  Jeffery K. Taubenberger,et al.  Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.

[15]  G. Gao,et al.  Highly Pathogenic H5N1 Influenza Virus Infection in Migratory Birds , 2005, Science.

[16]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.

[17]  Tokiko Watanabe,et al.  Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Webster,et al.  A pandemic warning? , 1997, Nature.

[19]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[20]  J. Taubenberger,et al.  Novel Origin of the 1918 Pandemic Influenza Virus Nucleoprotein Gene , 2004, Journal of Virology.

[21]  R. Webster,et al.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus , 1998, The Lancet.

[22]  M. Zambon,et al.  The pathogenesis of influenza in humans , 2001, Reviews in medical virology.

[23]  A. Klimov,et al.  Evolution of the receptor binding phenotype of influenza A (H5) viruses. , 2006, Virology.

[24]  Yoshihiro Kawaoka,et al.  PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. , 2004, Virology.

[25]  Y. Kawaoka,et al.  Human influenza a viral genes responsible for the restriction of its replication in duck intestine. , 2002, Virology.

[26]  Y. Guan,et al.  Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans * , 2002, Journal of medical virology.

[27]  J. Taubenberger,et al.  Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus , 2004, Nature Reviews Microbiology.

[28]  David J. Stevens,et al.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors , 2006, Nature.

[29]  R. Karron,et al.  Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers , 1992, Journal of clinical microbiology.

[30]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.